7 Reasons Why Millions of Americans Are Quietly Ditching Antacids - And What They're Using Instead
If you've been on Tums, Pepcid, or Prilosec for more than 3 months and you're still suffering, this is the most important thing you'll read today.
Reason 1: Antacids Are Treating the Wrong Problem — And the Science Proves It
Here is what actually happens when acid burns your throat or stomach.
Your tissue has lost its protective mucus coating. Acid, which has always been there, which you need to digest food is now making direct contact with raw, exposed tissue. That contact is the burning.
When you take a Tums, you neutralize some of that acid temporarily. The burning eases for 20 to 30 minutes.
Then your stomach produces more acid because your stomach is supposed to produce acid and the burning returns. Sometimes worse than before.
When you take a PPI like omeprazole, you suppress acid production dramatically. The burning quiets down. But the unprotected tissue is still there.
And the acid that does get produced, even reduced acid, is still making contact with raw tissue.
Neither approach tells your body to rebuild the barrier.
That is not a side effect of these medications. That is a design limitation. They were never built to do that job.
The compound that was built to do that job is called deglycyrrhizinated licorice — DGL.
And it has been sitting in peer-reviewed journals since 1971 while the $15 billion acid-suppression industry quietly looked the other way.
Reason 2: It Rebuilds the Protective Barrier Antacids Leave Destroyed
Your stomach and esophagus are supposed to be lined with a thick mucus layer — a protective gel coating roughly two millimeters deep that shields your tissue from the acid your stomach produces.
That layer thins as you age. Stress thins it. H. pylori infection destroys it directly.
Chronic NSAID use blocks the biological signal that rebuilds it. Years of acid exposure without protection erodes it further.
By the time most chronic GERD and gastritis sufferers are seeking help, that barrier is significantly compromised. The same acid that never bothered them at 22 is now burning through tissue that has no protection left.
Antacids do nothing to rebuild this barrier. They neutralize the acid that is burning through. The barrier stays exactly as depleted as it was.
DGL works through a completely different mechanism. It stimulates prostaglandin E2 synthesis in your gastric mucosal cells — a specific biological signal that tells your stomach to produce more protective mucus, accelerate cell renewal, and restore the coating that was always supposed to be there.
This mechanism was documented in a 1981 study in the European Journal of Pharmacology. It was confirmed in clinical trials published in the journal Gut in 1971 and 1973. In 1978, a head-to-head trial showed DGL matched Tagamet — the world's first blockbuster acid drug — for gastric ulcer healing.
It does not suppress your acid. It rebuilds your protection.
Reason 3: If You've Tried DGL Before and Felt Nothing — Here's the Documented Reason Why
This is the section most articles skip. I'm not going to skip it.
If you have tried DGL and got nothing from it, you are not wrong about the ingredient. You were almost certainly failed by the dose or the format — and in most cases, both.
Here is what the clinical trials that showed DGL working actually used: 380 to 760 milligrams per serving.
Here is what the most popular DGL chewable tablet on the market currently contains: 75 milligrams.
That product was reformulated several years ago. The original formula contained 760mg. The reformulated version contains 75mg — one tenth of the therapeutic dose. The packaging looks the same. The language is the same. The dose is a fraction of what the research validated.
That is why it did not work for you. Not because DGL doesn't work. Because you took ten percent of the dose that was actually studied.
The second problem is format. DGL must be chewed and mixed with saliva to activate. It works topically — by making direct contact with the mucosal lining from the moment of first swallow.
A capsule that dissolves in the intestine bypasses the entire site of action. The mechanism requires mucosal contact. Capsules do not provide it.
Chewable or gummy format is not a consumer preference. It is a biological requirement for DGL to function.
If you took DGL in a capsule at 75mg and felt nothing, you did not try DGL. You tried an ingredient that requires saliva activation at clinical dose, delivered in the wrong format at one tenth the necessary amount.
Reason 4: It Quiets the Inflammation That Keeps the Damage From Healing
Most people understand that their stomach is damaged. Fewer understand why it won't heal on its own — even when the original cause (H. pylori, acid, NSAIDs) has been addressed.
The reason is chronic inflammation.
In a stomach or esophagus with active gastritis, Barrett's damage, or post-H. pylori mucosal injury, the tissue is dominated by inflammatory cytokines — specifically IL-6, IL-8, and TNF-α.
These are the biological agents that keep tissue in a state of active breakdown. They are part of the immune response.
This inflammatory environment actively counteracts mucosal repair. You can send the signal to rebuild the barrier — which DGL does — but if IL-6 and TNF-α are elevated in the tissue simultaneously, the repair process is fighting against a countervailing force that is designed to break tissue down.
This is where chamomile comes in. Not chamomile tea — a standardized extract of German chamomile, Matricaria chamomilla, at a therapeutic dose.
German Commission E — the German government's regulatory body for herbal medicines, equivalent to the FDA for botanicals — formally approved chamomile for inflammatory diseases of the gastrointestinal tract. Not for relaxation. Specifically for GI inflammation.
The mechanism: chamomile's primary flavonoids, apigenin and quercetin, inhibit NF-κB — the master switch that drives inflammatory cytokine production. A 2020 study in the Journal of Ethnopharmacology documented chamomile reducing MCP-1, IL-6, IL-8, and TNF-α — the exact inflammatory markers elevated in chronic gastritis and Barrett's esophagus.
DGL rebuilds the barrier. Chamomile clears the inflammatory environment that would otherwise prevent the rebuild from taking hold.
Without both mechanisms working simultaneously, you are asking your body to repair a structure while the process that damaged it continues running in the background.
Reason 5: It Stops the 3 AM Wake-Ups That Antacids Can't Touch
If you wake up choking on acid at 2 or 3 AM, antacids cannot help you.
Here is why. You took the antacid before bed. It neutralized the acid present at that moment. Four hours later while you are asleep, your stomach has produced more acid — because your stomach produces acid continuously, as it is designed to do.
That acid is now sitting on unprotected tissue with no barrier between them. You wake up burning.
The antacid did its job. It just did not do the right job.
What the 3 AM symptom tells you clinically is that the mucosal barrier is severely compromised. When the barrier is intact, nighttime acid production does not cause symptoms — the tissue is protected.
When the barrier is gone, every acid production cycle becomes a potential wake-up event.
Rebuilding the barrier — the job that DGL is specifically designed to do — addresses the root cause of nighttime symptoms in a way that acid neutralization never can. When the tissue has protection, the acid that is produced while you sleep does not reach raw tissue.
Additionally, the anti-inflammatory effect of chamomile reduces the tissue reactivity that makes the mucosal surface hypersensitive to even small amounts of acid exposure.
Calmer, less inflamed tissue has a higher threshold for the burning signal — which means less disrupted sleep even before the barrier is fully rebuilt.
Reason 6: No Long-Term Side Effects — Unlike What You May Already Be Taking
If you have been on a PPI for more than 6 months, you need to read this section carefully.
Proton pump inhibitors were approved by the FDA for short-term use. Four to eight weeks. That was the original indication.
The average American with chronic reflux has been on one for six years.
Long-term PPI use has been associated in peer-reviewed literature with the following:
Kidney damage — 96% increased risk of kidney failure and 29% increased risk of chronic kidney disease compared to patients taking alternative medications (Washington University, Lazarus et al.)
Bone fractures — 44% increased fracture risk from calcium and magnesium depletion. Takeda Pharmaceutical settled lawsuits in 2014 alleging Prevacid was linked to increased fracture risk.
B12 deficiency — occurring in up to 65% of long-term users, producing fatigue, brain fog, memory problems, and neurological symptoms
Magnesium depletion — severe enough in some cases to cause cardiac arrhythmia; subject of an FDA warning
Rebound acid hypersecretion — when you try to stop, your stomach produces dramatically more acid than before you started, because it was compensating for the suppression the entire time. This rebound is documented in peer-reviewed research and is the mechanism that keeps millions of people on a drug they were supposed to take for eight weeks.
There are currently 18,706 lawsuits filed in US federal court alleging that Nexium and Prilosec caused permanent kidney damage. AstraZeneca settled for $425 million in October 2023.
DGL has been used for gastric conditions for over 3,000 years. It appears in the Ebers Papyrus — Egyptian medical records dating to 1550 BC. It is documented in Traditional Chinese Medicine, Ayurveda, and Greek medicine. It was used in the British Pharmacopoeia in the 1940s and 1950s for ulcer treatment.
Chamomile has been approved by German Commission E for GI inflammatory conditions. Approximately one million cups of chamomile tea are consumed globally per day.
No kidney damage. No fracture risk. No B12 depletion. No rebound when you stop.
Reason 7: Actually Eat and Live Like a Normal Person Again
This is what every person with chronic GERD, gastritis, or post-H. pylori damage actually wants.
Not a lower symptom score on a clinical questionnaire.
Not "manageable" reflux.
The ability to go to a restaurant and order what they want. To drink coffee in the morning without calculating the cost. To sleep flat. To travel without packing a pharmacy. To eat at someone else's house without quietly cataloguing the risk of every dish.
When you are only suppressing acid, you are always one wrong bite away from suffering. The protection is chemical and temporary. Every meal is a negotiation.
When the barrier is rebuilt and the inflammatory environment is addressed, the calculation changes. The tissue has protection. Trigger foods become less triggering — not because you have trained yourself to avoid them, but because the surface they are contacting is no longer raw and exposed.
Patients in clinical trials using DGL reported reintroducing foods they had avoided for years within the first 60 to 90 days. Coffee. Wine. Spicy food. Not recklessly — but without the constant fear that had replaced the simple act of eating.
That is not symptom management. That is what fixing the underlying problem actually looks like.
My Recommendation: What makes Licollie different from every other DGL product:
Licollie is a pectin-based (vegan friendly) gummy that is chewable by design, containing 400mg of DGL per serving. That is within the 380 to 760mg clinically validated range. It is more than five times the dose in the reformulated market-leading chewable.
Each serving also contains 75mg of standardized chamomile extract, specifically standardized for apigenin content — the flavonoid responsible for the NF-κB inhibition and cytokine suppression documented in the peer-reviewed literature.
Taken 20 minutes before meals. Two gummies. The gummy dissolves on chewing, beginning mucosal contact immediately — in the mouth, down the esophagus, coating the stomach wall before food arrives.
Clinical-dose DGL. Correct format. Paired anti-inflammatory. Nothing else on the market combines all three.
The 60-Day Guarantee
Mucosal repair takes time. 30 days is not enough to know whether the barrier is rebuilding. That is why Licollie comes with a full 60-day money-back guarantee — no questions asked.
If you complete 60 days and do not feel a meaningful difference, you pay nothing.
The only risk is spending another two months doing what you are already doing.
Licollie is available exclusively through the official store. Due to increased demand following recent research on long-term antacid use, inventory is limited.
Today: $22.6
(was $39.99)
First time customer discount automatically applied through link to shop below.